Chang-Seok Ki

Title: Chang-Seok Ki: Innovator in ALS Diagnostics

Introduction

Chang-Seok Ki is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in relation to amyotrophic lateral sclerosis (ALS). With a total of 3 patents, his work focuses on innovative methods for detecting and diagnosing this challenging condition.

Latest Patents

Chang-Seok Ki's latest patents include a diagnostic composition for ALS that utilizes acid sphingomyelinase (ASM). This invention outlines a method for detecting diagnostic markers for ALS by measuring the ASM expression level or enzyme activation level in a subject's sample. The findings indicate that ASM activity is specifically elevated in ALS patients compared to healthy individuals, making it a potential marker for effective diagnosis. Another notable patent involves a detection kit for the c-Met gene, which includes a primer set and a cleavable probe. This kit is designed to efficiently detect low concentrations of c-Met gene expression, aiding in cancer diagnosis and prognosis.

Career Highlights

Throughout his career, Chang-Seok Ki has worked with reputable organizations, including the Samsung Life Public Welfare Foundation and the Kyungpook National University Industry-Academic Cooperation Foundation. His experience in these institutions has allowed him to collaborate on various research projects aimed at advancing medical diagnostics.

Collaborations

Chang-Seok Ki has collaborated with notable colleagues, including Kwang Woo Kim and Jong Won Kim. Their joint efforts have contributed to the development of innovative diagnostic methods and technologies.

Conclusion

Chang-Seok Ki's work in ALS diagnostics exemplifies the impact of innovation in the medical field. His patents and collaborations highlight the importance of research in developing effective diagnostic tools for complex diseases.